The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced Exponential Medicine Founder Daniel Kraft would deliver the keynote address for its upcoming meeting in New Orleans, Louisiana. ISPOR's meeting is slated to kick off May 18 and last through May 22. The keynote […]
Deloitte’s Reh Says Trump Rebate Proposal Could Boost Value-Focused Competition
The Trump administration's point-of-sale rebate proposal could bolster value-centered competition, Deloitte Vice Chairman and life science chief Greg Reh says. According to an InsideHealthPolicy report, Reh said assessing a drug's effectiveness against alternative treatments could enable drugmakers […]
Biotech Firms Look to Outcomes-Based Pricing
Bluebird Bio is one of the latest biotech companies moving toward value-based pricing models after announcing in January it would split payments for its gene therapy to cure inherited blood disorder into five yearly installments, according to an article published in the Atlantic. According to the […]
Franklin Pharmaceutical Consulting Expands Senior Team
Franklin Pharmaceutical Consulting (FPC) on Monday, April 22, announced a new addition to its senior ranks with the appointment of Nathan White as the new senior vice president and head of value and access. According to a press release, White brings to the table more than 10 years of experience in […]
Release of Reinhardt’s Latest Book Nears
Uwe Reinhardt's newest book, "Priced Out: The Economic and Ethical Costs of American Health Care," is slated to publish posthumously next month, and will feature forwards by Paul Krugman, New York Times columnist, and former legislator Bill Frist, according to Managed Care magazine. The book is […]
NICE to Discuss New META Module at Med-Tech Innovation Expo
The National Institute for Health and Care Excellence (NICE) is slated to discuss a new module to its Medtech Early Technical Assessment (META tool) during the upcoming Med-Tech Innovation Expo in Birmingham, U.K. Jeanette Kusel, director for the National Institute for Health and Care Excellence […]
Magill: Biopharma Must be Open to New Pathways
The biopharmaceutical industry should maintain its high standards for evidence and data, but should also be open to new pathways for evidence as interest in real-world evidence continues to grow, Aetion CEO Carolyn Magill writes in a recent article published on MedCity News. Magill points to the […]
Article: Time is Biggest Obstacle to Shared Decision Making
While shared decision making is vital in a patient's care during a host of complex situations, time is cited by patients and clinicians as the most significant obstacle, according to an article published on JAMA. "Time can be considered an organizing tool that controls what happens and when," the […]
Health Canada Increases Interest in RWE, Encourages Submissions
Health Canada is walking in tandem with the U.S. as it is looks to evaluate how it could better implement real-world evidence and tackle some key concerns, according to a Regulatory Affairs Professionals Society report. "We encourage RWE submissions (1) that aim to expand evidence-based indications […]
NHC Spotlights FDA’s Roadmap on Patient-Focused Outcome Measurement
The National Health Council (NHC) in a recent post outlines the Food and Drug Administration's (FDA) Roadmap to Patient-Focused Outcome Measurement in Clinical Trials. The council also recently hosted a webinar on the FDA's effort "to help researchers understand and then develop new or adapt […]
ISMPP Releases Open Access White Paper
The International Society for Medical Publication Professionals (ISMPP) during its recent meeting in National Harbor, Maryland, released a new open access white paper, "A Multistakeholder Discussion on Open Access and Medical Publishing." The release marks ISMPP's first-ever white paper, according […]
Case Study Outlines Premera Blue Cross Data Solution
A new case study sponsored by InterSystems outlines how Premera Blue Cross's data solution combines claims and clinical data to bolster health care and overall business performance. "Forward looking health plans need a near real-time view into the health and care of their members, and into their […]
ISPOR Announces 2019 HEOR Awards
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) on Monday, April 15, announced the honorees for this year's HEOR Scientific and Leadership Awards. According to a release, the awards are "designed to foster and recognize excellence and outstanding technical achievement […]
AMCP Seeks Members for Market Insights Survey Panel
The Academy of Managed Care Pharmacy (AMCP) is looking for members to take part in its Market Insights Survey Panel. According to an email, AMCP is working to generate insights on a "variety of health care topics, including chronic conditions, market dynamics and new products." Survey assignments […]
HealthEconomics.Com Seeks Input for 2019 Salary Survey
HealthEconomics.Com is seeking stakeholder input on its 3rd Bi-Annual 2019 HEOR, RWE & Market Access Global Salary Survey. The roughly 10-minute survey aims to evaluate the career information of health economics and outcomes research (HEOR), real-world evidence (RWE) and Market Access (MA) […]
AMCP Nexus Issues Call for Poster Abstracts
The Academy of Managed Care Pharmacy (AMCP) has issued a call for post abstracts as it gears up for its AMCP Nexus 2019 meeting in Maryland. The event is scheduled for Oct. 29-Nov. 1. According to an email, the submission deadline for abstracts is 3:30 p.m. EST June 12. Authors will receive word […]
ICER Posts Draft Scoping Document for RA Treatments
The Institute for Clinical and Economic Review (ICER) on Thursday, April 11, released a draft scoping document for a planned review of treatments for rheumatoid arthritis (RA). According to a press release, ICER's assessment will include new data on RA treatments since its 2017 review. "In […]
BIO’s Greenwood: Transparency in Pharma Value Chain ‘Overdue’
Jim Greenwood, president and CEO of the Biotechnology Innovation Organization, in a recent column published on The Hill writes that increased attention by policymakers on pharmacy benefit managers is movement toward "overdue transparency within the pharmaceutical value chain." While PBMs were […]
Sanofi Unveils Subscription Program for Insulin
Drugmaker Sanofi has revealed a new subscription-like model for its insulin treatment, according to a FiercePharma report, and is charging $99/month to receive the drug. According to the report, Sanofi through its program is offering patients 10 boxes of insulin pens and 10 mL vials each […]
PBMs Point Fingers at Pharma for High Prices
Representatives from the top pharmacy benefit managers looked to shift blame off itself for high drug prices onto pharmaceutical companies during a Senate Finance Committee hearing on Tuesday, CNBC reports. Five executives representing CVS Health, Cigna, Prime Therapeutics, Human and […]
Sweetenham Spotlights Possible Benefits, Problems with RWE in Oncology
John Sweetenham, senior director of clinical affairs and executive medical director of Huntsman Cancer Institute at The University of Utah, in a recent write up takes a look at some of the potential benefits real-world evidence (RWE) has to offer in oncology, as well as some of the possible […]
Broadcasting, Advertising Groups Oppose Rule on Drug Prices in Ads
Bringing a new swath of opposition to the Trump administration's rule requiring drugmakers to include drug prices in their commercials, broadcasting and advertising groups say the rules could put a significant dent in a key revenue stream, The Hill reports. The Association of National Advertisers […]
Hospitals, Insurers Eye Drug Rebate Rule
Insurers and hospitals say the Centers for Medicare and Medicaid Services (CMS) should include in a recently-proposed rule some new requirements for pharmaceutical companies, Modern Healthcare reports. Organizations in response to the rule suggested that eliminating safe harbor for Medicare Part D […]
TEDMED 2020 Slated to Kick Off March 2
TEDMED 2020 is set for March 2-4 in Boston, the TEDMED team announced this week, with early-bird registration slated to open May 15. TEDMED in an email said it was "excited to bring our diverse, multi-disciplinary community Boston." "TEDMED is dedicated to inspiring change in health and medicine, […]
ICER Releases Report on Peanut Allergy Treatments
The Institute for Clinical and Economic Review on Tuesday, April 9, released a draft evidence report on the clinical effectiveness and value of DBV Technologies' Viaskin Peanut and Aimmune Therapeutics' AR101 for inducing immune tolerance to peanuts. The report will be open to public comment until […]
PBMs Testify Before Senate Finance Committee
Pharmacy benefit managers mostly dodged questions from policymakers during a Senate Finance Committee hearing Tuesday, STAT reports. However, Sens. Chuck Grassley (R-Iowa) and Ron Wyden (D-Ore.) floated the possibility of legislative action. "Ranking member Wyden and I are committed to working on […]
Survey Finds Big Push to Bolster Data Analytics Strategies
Health care organizations are looking to ramp up their efforts to develop big data analytics solutions to tackle the logistics of value-based health care, a new survey from Deloitte Center for Health Solutions suggests. The survey found that 70 percent of health organizations have developed a […]
Report: Competition High for Data Scientists
A new study published in the Journal of the American Medical Informatics Association suggests providers, payers and health IT vendors are heavily competing for experienced data scientists. According to a HealthITAnalytics report, the analysis found stiff competition for experts familiar with common […]
Policymakers Move on Drug Pricing Bill
House legislators are moving forward with legislation aimed at reducing drug prices after House Energy and Commerce Committee Chairman Frank Pallone Jr., a Democrat, and Republican Rep. Greg Walden reached a bipartisan deal, The Hill reports. The bill was expected to advance out of committee […]
AMCP Seeks Comments on Framework
The Academy of Managed Care Pharmacy (AMCP) is seeking stakeholder input as it works to update its "Format for Formulary Submissions" framework. The deadline to submit feedback is Thursday, April 11. AMCP says it's updating the framework to align with the Food and Drug Administration's […]
